US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.32

+0.38001.03%

Volume:10.11K

Turnover:376.72K

Market Cap:869.93M

PE:- -

High:37.38

Open:36.94

Low:36.94

Close:36.94

52wk High:38.19

52wk Low:28.26

Shares:23.31M

Float Shares:23.31M

Volume Ratio:0.84

T/O Rate:0.04%

Dividend:0.22

Dividend Rate:0.59%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ultragenyx confirms FDA approval of Fayuvi

'I'm Burned Out': I'm Constantly Helping My Cousin Who is Running Out of Money. is it Too Much to Expect His Sister to Help?

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

'I'm Burned Out': I'm Constantly Helping My Cousin Who is Running Out of Money. is it Too Much to Expect His Sister to Help?

Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

Cambium Bio Plans New Share Placement to Bolster Capital Base

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits

Barclays downgrades Scholar Rock on valuation after FDA approval

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine

Prescient Therapeutics Extends Securities Purchase Plan Deadline

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/RSPH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.32,"timestamp":1790259839240,"preClose":36.94,"halted":0,"volume":10110,"delay":0,"changeRate":0.0102869518137521,"floatShares":23310000,"shares":23310000,"eps":0,"marketStatus":"Trading","change":0.38,"latestTime":"09-24 10:24:19 EDT","open":36.94,"high":37.38,"low":36.94,"amount":376721.7519,"amplitude":0.011911,"askPrice":37.35,"askSize":1041,"bidPrice":37.28,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790280000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":36.94,"sharesOutstanding":23410000,"nav":37.17799,"aum":866618946.9,"dividendRate":0.005938,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.94,"preClose":36.94,"latestTime":"08:12 EDT","volume":1,"amount":36.94,"timestamp":1790251942763,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.94,"preClose":36.94,"latestTime":"19:30 EDT","volume":24,"amount":884.66,"timestamp":1790206202530,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.842325,"impliedVol":0.0046,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23310000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.842325,"shares":23310000,"dividePrice":0.2216,"high":37.38,"amplitude":0.011911,"preClose":36.94,"low":36.94,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.32,"committee":-0.020088,"eps":0,"divideRate":0.005938,"volume":10110,"delay":0,"ttmEps":0,"open":36.94,"prevYearClose":31.85,"prevWeekClose":36.73,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.97,"twentyDayClose":37.84,"sixtyDayClose":33.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","MRNX","BK4139","GDOC","NVIB","MRNY","TECB","FRTY","MEDI","BBP","RARE","IDNA","BK4588","SYNB","RSPH","IBB","BK4585","BMED","GNMX","XLVX","TBXU","PSCH","PINK","IYH","IEIH","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668640099","title":"'I'm Burned Out': I'm Constantly Helping My Cousin Who is Running Out of Money. is it Too Much to Expect His Sister to Help?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668640099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668640099?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:15","pubTimestamp":1789647300,"startTime":"0","endTime":"0","summary":"The CousinRelated: 'I'm not interested in long-term care insurance': I'd like to retire at 55. How much will I have to pay for healthcare?You can email The Moneyist with any financial and ethical questions at qfottrell@marketwatch.com. The Moneyist regrets he cannot reply to questions individually.Your cousin's sister may have a vested interest in your cousin not selling this property or going to a Medicaid-approved nursing home.Dear Cousin,You know the old saying: There are no victims, only volunteers.You have willingly decided to help your cousin navigate his retirement years, spend time with him by taking him for lunches/dinners and put a plan in place for him so he can live comfortably without running out of money.At the same time, you have resentments towards his sister who you believe - rightly or wrongly - that she should pitch in and help. You believe she is reneging on her duties to her sibling, and wonder why she doesn't do more.So I have two pi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","PINK","GNMX","IYH","FRTY","NVIB","LFSC","MRNY","SYNB","BK4007","LABU","MEDI","PSCH","GDOC","TECB","BK4585","BBP","BMED","XLVX","BK4588","TBXU","IDNA","NUVB","RSPH","IEIH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961247","title":"Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961247?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:31","pubTimestamp":1789644661,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has provided an announcement. Tiziana Life Sciences Ltd is a biotechnology company developing immunomodulation th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-signs-saudi-collaboration-mou-for-new-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-signs-saudi-collaboration-mou-for-new-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BK4588","IBB","JDOC","FHLC","LNGR","IEIH","SYNB","DARP","RSPH","XT","BK4585","BBP","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","MEDI","BBP","RSPH","BK4585","BAYRY","NVIB","BK4588","PSCH","TBXU","SYNB","IDNA","LABU","GDOC","IEIH","MRNX","BK4007","TECB","IBB","XLVX","FRTY","MRNY","IYH","GNMX","BMED","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668974968","title":"'I'm Burned Out': I'm Constantly Helping My Cousin Who is Running Out of Money. is it Too Much to Expect His Sister to Help?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668974968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668974968?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:15","pubTimestamp":1789636500,"startTime":"0","endTime":"0","summary":"The CousinRelated: 'I'm not interested in long-term care insurance': I'd like to retire at 55. How much will I have to pay for healthcare?You can email The Moneyist with any financial and ethical questions at qfottrell@marketwatch.com. The Moneyist regrets he cannot reply to questions individually.Your cousin's sister may have a vested interest in your cousin not selling this property or going to a Medicaid-approved nursing home.Dear Cousin,You know the old saying: There are no victims, only volunteers.You have willingly decided to help your cousin navigate his retirement years, spend time with him by taking him for lunches/dinners and put a plan in place for him so he can live comfortably without running out of money.At the same time, you have resentments towards his sister who you believe - rightly or wrongly - that she should pitch in and help. You believe she is reneging on her duties to her sibling, and wonder why she doesn't do more.So I have two pi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933761","title":"Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933761?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:03","pubTimestamp":1789588997,"startTime":"0","endTime":"0","summary":"Affinor Growers ( ($TSE:AFI) ) has issued an update. Affinor Growers has appointed biotechnology and sustainable agriculture innovator Dr. Hyder Kh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","FTAG","IBB","PJBF","DARP","AGNG","BK4585","SDG","FWD","BBP","BK4588","LNGR","IVEG","RSPH","IEIH","SDGS","JDOC","KROP","XT","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133238050","title":"Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1133238050","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133238050?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:43","pubTimestamp":1789544611,"startTime":"0","endTime":"0","summary":"In 2026, the Ulanqab Municipal Market Regulation Bureau in Inner Mongolia has closely aligned with the regional sampling work deployment, making steady progress in its medical device quality control...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","GDOC","BK1574","BK1100","AGNG","MDEV","MEDX","RSPH","BK1583","LGHT","LNGR","09996","HART","IEIH","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679025","title":"Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679025?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:57","pubTimestamp":1789527450,"startTime":"0","endTime":"0","summary":"The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical Limited, an ASX-listed biotechnology company, has reported changes...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","JDOC","IBB","BBP","BK4585","LNGR","RSPH","FHLC","IEIH","FWD","XT","BK4588","AGNG","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676156","title":"Cambium Bio Plans New Share Placement to Bolster Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676156?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:52","pubTimestamp":1789523532,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regeneus Ltd. ( ($AU:CMB) ). Cambium Bio Limited, trading on the ASX under the ticker CMB, is a biotechnology c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","IEIH","FWD","RSPH","FHLC","XT","JDOC","BBP","LNGR","DARP","SYNB","AGNG","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["GDOC","RSPH","MEDI","MRNX","TECB","PSCH","IEIH","XBIX","TBXU","SYNB","BMED","GNMX","LABU","IBB","MRNY","IDNA","LFSC","NVIB","XLVX","BBP","IYH","BK4588","FRTY","BK4585","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140666287","title":"Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1140666287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140666287?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:06","pubTimestamp":1789473999,"startTime":"0","endTime":"0","summary":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688426","MEDX","PCR","BK1100","LGHT","BK1574","159883","IEIH","MDEV","PTH","09996","BK1583","GDOC","HART","BK0239","LNGR","AGNG","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178547175","title":"Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=1178547175","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178547175?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:24","pubTimestamp":1789471463,"startTime":"0","endTime":"0","summary":"Shanghai Kehua Bio-Engineering Co., Ltd. (SZSE: 002022) has announced that it, along with its controlled subsidiary Suzhou Tianlong Biotechnology Co., Ltd., has received medical device registration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HART","LGHT","MDEV","159883","PTH","LNGR","BK1583","BK0239","BK1574","RSPH","AGNG","BK0188","BK0046","IEIH","BK0028","MEDX","09996","002022","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IYH","IEIH","MEDI","LABU","NVIB","XLVX","BBP","PINK","LFSC","IDNA","TSPA","FRTY","BMED","MRNY","GDOC","TACU","RSPH","CDIG","GNMX","TBXU","TECB","SYNB","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661509","title":"Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661509","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661509?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:47","pubTimestamp":1789447668,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, develops medical therap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","BK4588","DARP","FHLC","JDOC","RSPH","SYNB","IBB","BBP","AGNG","XT","LNGR","FWD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124014323","title":"Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1124014323","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124014323?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:16","pubTimestamp":1789438610,"startTime":"0","endTime":"0","summary":"According to a research report released by Zheshang Securities Co.,Ltd., the external environment and internal growth drivers across medical device sub-sectors are expected to diverge in the second...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","MDEV","601878","AGNG","PTH","RSPH","LNGR","LGHT","BK1574","GDOC","BK1100","MEDX","HART","IEIH","159883","09996","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667316690","title":"Prescient Therapeutics Extends Securities Purchase Plan Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667316690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667316690?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:02","pubTimestamp":1789437732,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) just unveiled an update. Prescient Therapeutics Limited, an ASX-listed biotechnology company trading u...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FWD","IEIH","BBP","IBB","JDOC","RSPH","SYNB","XT","DARP","BK4139","FHLC","LNGR","BK4585","BK4539","LENZ","BK4007","BK4588","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694618","title":"Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667694618?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:16","pubTimestamp":1789431375,"startTime":"0","endTime":"0","summary":"Syntara Limited ( ($AU:SNT) ) has provided an update. Syntara Limited, an ASX-listed clinical-stage biotechnology company based in Sydney, develops...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","BK4588","LNGR","DARP","XT","FWD","AGNG","BK4585","RSPH","BBP","IBB","IEIH","FHLC","BBC","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BBP","IBB","IEIH","AGNG","HELX","FHLC","JDOC","RSPH","GNMX","HTEC","BK4585","LNGR","BK4588","XT","SYNB","FWD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664069","title":"Addus HomeCare Consolidation Can't Offset Medicaid Funding Pressures, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664069","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664069?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:59","pubTimestamp":1789397969,"startTime":"0","endTime":"0","summary":"Addus HomeCare's (ADUS) exposure to Medicaid funding pressures is expected to be offset by potential benefits from industry consolidation, although slowing state reimbursement rates could constrain gr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RSPH","IE00BN0W2V16.EUR","BK4196","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","ADUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}